EDGEWISE THERAPEUTICS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 18.01 USD | +2.91% |
|
+5.63% | +64.63% |
| 24/06 | Edgewise Therapeutics, Inc.(NasdaqGS:EWTX) added to S&P Pharmaceuticals Select Industry Index | CI |
| 10/05 | Wedbush Raises Edgewise Therapeutics' PT to $31 From $26, Keeps Outperform Rating | MT |
Chart calendar Edgewise Therapeutics, Inc.
2fe5867.RgHxcIaeLTfVUiFA0MHV3wsGv3sj75ImKorI0JeXvcc.DmS_RODneXu_GRYw4Y6zkUd01QhagtNkU9KOiKDY05YsVYUl9f9IY5gjcA~f74ec7f1b8c40f4ded98c0bc0bb9132e
Upcoming events on Edgewise Therapeutics, Inc.
Past events on Edgewise Therapeutics, Inc.
| 07/06/2024 09:30 pm | Annual General Meeting |
| 16/05/2024 01:05 am | RBC Capital Markets Global Healthcare Conference |
| 09/05/2024 05:30 pm | Q1 2024 Earnings Release |
| 16/04/2024 10:42 pm | American Academy of Neurology Meeting |
| 16/04/2024 06:00 pm | ARCH EDG-5506 Two Year Topline Study Results |
| 02/04/2024 11:50 pm | Cantor Fitzgerald Muscular Dystrophy Symposium |
| 11/03/2024 09:30 pm | Leerink Partners Global Biopharma Conference |
| 06/03/2024 09:45 pm | Muscular Dystrophy Association Clinical & Scientific Conference |
| 04/03/2024 | Muscular Dystrophy Association Clinical & Scientific Conference - Poster Number: M146 |
| 04/03/2024 | Muscular Dystrophy Association Clinical & Scientific Conference - Poster Number: M147 |
| 04/03/2024 | Muscular Dystrophy Association Clinical & Scientific Conference - Poster Number: M145 |
| 22/02/2024 06:30 pm | Q4 2023 Earnings Release |
| 10/01/2024 12:00 am | JPMorgan Healthcare Conference |
| 29/11/2023 06:30 pm | Piper Sandler Healthcare Conference |
| 15/11/2023 09:25 pm | Stifel Healthcare Conference |
| 14/11/2023 12:50 am | American Heart Association Scientific Meeting |
| 11/11/2023 10:00 pm | American Heart Association Scientific Meeting |
| 09/11/2023 06:30 pm | Q3 2023 Earnings Release |
| 06/10/2023 11:30 pm | World Muscle Society International Congress - Effects of EDG-5506 |
| 06/10/2023 11:30 pm | World Muscle Society International Congress - Development of a conceptual |
Annual results
| Fiscal Period | December | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 | -42,9 -41,7 -2.86% | -71,3 -69,7 -2.29% | -113 -109 -3.28% | -141 |
|
EBIT Million USD | Released Forecast Spread | 0,00 | -43,2 -42,0 -2.9% | -71,7 -70,4 -1.78% | -114 -111 -3.05% | -146 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -42,8 -43,0 0.51% | -67,6 -69,8 3.15% | -100 -97,2 -3.08% | -129 |
|
Net income Million USD | Released Forecast Spread | -17,1 | -42,8 -43,9 2.39% | -67,6 -69,3 2.43% | -100 -98,3 -1.94% | -132 |
|
EPS USD | Released Forecast Spread | -0,12 | -1,14 -1,17 2.8% | -1,26 -1,32 4.59% | -1,57 -1,55 -1.46% | -1,60 |
| Announcement Date | 05/03/21 | 24/02/22 | 23/02/23 | 22/02/24 | - |
Quarterly results
| Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
|
EBITDA Million USD | Released Forecast Spread | -14,7 -14,0 -5.62% | -16,4 -16,8 2.6% | -18,2 -18,9 4.15% | -22,0 -21,7 -1.35% | -25,5 -23,6 -8.23% | -25,6 | -29,0 -26,4 -9.85% | -33,4 -29,5 -13.09% | -34,3 -29,3 -17.02% | -34,7 | -35,2 | -36,2 | ||
|
EBIT Million USD | Released Forecast Spread | -14,8 -13,8 -7.06% | -16,5 -16,3 -1.22% | -18,3 -18,4 0.87% | -22,1 -20,9 -5.73% | -25,7 -22,7 -13.37% | -25,3 -26,4 4.18% | -29,5 -26,9 -9.34% | -33,9 -30,7 -10.34% | -34,8 -33,6 -3.33% | -34,9 | -36,9 | -39,5 | -40,7 | -43,8 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -14,7 -13,8 -6.19% | -16,1 -16,9 4.65% | -17,5 -19,0 7.78% | -19,4 -21,7 10.63% | -22,8 -23,6 3.33% | -21,5 -24,5 12.37% | -25,7 -24,5 -4.95% | -30,1 -27,2 -10.96% | -28,5 -30,1 5.34% | -32,0 | -33,5 | -34,6 | -40,7 | -43,8 |
|
Net income Million USD | Released Forecast Spread | -14,7 -13,9 -5.44% | -16,1 -16,7 3.79% | -17,5 -18,7 6.34% | -19,4 -21,2 8.35% | -22,8 -23,4 2.47% | -21,5 -25,5 15.73% | -25,7 -25,9 0.82% | -30,1 -28,3 -6.61% | -28,5 -31,4 9.23% | -32,8 | -34,4 | -35,7 | -40,7 | -43,8 |
|
EPS USD | Released Forecast Spread | -0,30 -0,28 -6.19% | -0,32 -0,34 4.95% | -0,34 -0,36 5.15% | -0,31 -0,36 13.24% | -0,36 -0,37 1.94% | -0,34 -0,41 16.42% | -0,41 -0,41 -0.37% | -0,47 -0,44 -5.98% | -0,33 -0,40 16.67% | -0,36 | -0,37 | -0,39 | -0,38 | -0,42 |
| Announcement Date | 11/05/22 | 04/08/22 | 03/11/22 | 23/02/23 | 11/05/23 | 10/08/23 | 09/11/23 | 22/02/24 | 09/05/24 | - | - | - | - | - |
| 15/07/2024 11:15 am | ADDLIFE AB: Q2 2024 Earnings Release |
| 22/07/2024 | MEDPACE HOLDINGS, INC.: Q2 2024 Earnings Release |
| 24/07/2024 | SYNGENE INTERNATIONAL LIMITED: Q1 2025 Earnings Release (Projected) |
| 24/07/2024 | ALKERMES PLC: Q2 2024 Earnings Release (Projected) |
| 24/07/2024 | IQVIA HOLDINGS INC.: Q2 2024 Earnings Release (Projected) |
| 24/07/2024 | ICON PUBLIC LIMITED COMPANY: Q2 2024 Earnings Release (Projected) |
| 25/07/2024 | LONZA GROUP AG: Q2 2024 Earnings Release |
| 25/07/2024 10:30 am | BACHEM HOLDING AG: Q2 2024 Earnings Release |
| 26/07/2024 | PHARVARIS N.V.: Q2 2024 Earnings Release (Projected) |
| 26/07/2024 10:30 am | BB BIOTECH AG: Q2 2024 Earnings Release |
Past sector events for Edgewise Therapeutics, Inc.
| 07/06/2024 12:27 pm | POLARIS GROUP: May 2024 Sales and Revenue Release |
| 30/05/2024 01:31 am | IMMUNOVANT, INC.: Q4 2024 Earnings Release |
| 23/05/2024 04:30 pm | CUREVAC N.V.: Q1 2024 Earnings Release |
| 22/05/2024 10:30 am | EVOTEC SE: Q1 2024 Earnings Release |
| 22/05/2024 02:44 am | ALVOTECH: Q1 2024 Earnings Release |
| 21/05/2024 04:30 pm | EXSCIENTIA PLC: Q1 2024 Earnings Release |
| 17/05/2024 11:30 am | BIOARCTIC AB: Q1 2024 Earnings Release |
| 16/05/2024 01:35 am | CULLINAN THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 15/05/2024 04:30 pm | PERSPECTIVE THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 15/05/2024 | GNI GROUP LTD.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- EWTX Stock
- Calendar Edgewise Therapeutics, Inc.
